Synthes & Generic Implant Company CEO Trade Lawsuits

Emerge Medical CEO John Marotta, who previously served as a sales representative for Synthes, recently filed a counterclaim against Synthes alleging antitrust violations, according to a Mass Device report.

Advertisement

Synthes filed a suit against Mr. Marotta and others, alleging their work with Emerge Medical, a generic orthopedic device company, violated non-compete agreements. Mr. Marotta resigned from Synthes in 2010, saying he would join a non-competitor, but Synthes says Emerge Medical’s cheaper generic devices compete with Synthes.

The counterclaim alleges that Synthes violated antitrust statutes and sent letters to Emerge Medical customers with misleading information, according to the report.

More Articles on Orthopedic Devices:

Wright Medical Group Launches CLAW II for Foot & Ankle Surgery

Biomet Makes $280M Offer on DePuy’s Trauma Business

Expanding Orthopedics Receives Patent for Spinal Devices

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.